Afamelanotide · source year

Afamelanotide research records in 2022

1 selected, source-linked Afamelanotide records carrying a 2022 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.

Dated records

1 selected record.

Evidence types

1 represented type.

Cited sources

1 distinct public record.

Explore 2022 by evidence type

1 type

Cited chronology

Afamelanotide records dated 2022

Open in the filterable feed →

December 2022

1 record

Literature metadata

Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians.

PubMed lists PMID 31987791 in Journal of the American Academy of Dermatology as Letter, Randomized Controlled Trial, with publication-date metadata of 2020-01-25 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗